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Pak1 protein kinase of Schizosaccharomyces pombe, a member of the p21-GTPase-activated protein kinase
(PAK) family, participates in signaling pathways including sexual differentiation and morphogenesis. The
regulatory domain of PAK proteins is thought to inhibit the kinase catalytic domain, as truncation of this
region renders kinases more active. Here we report the detection in the two-hybrid system of the interaction
between Pak1 regulatory domain and the kinase catalytic domain. Pak1 catalytic domain binds to the same
highly conserved region on the regulatory domain that binds Cdc42, a GTPase protein capable of activating
Pak1. Two-hybrid, mutant, and genetic analyses indicated that this intramolecular interaction rendered the
kinase in a closed and inactive configuration. We show that Cdc42 can induce an open configuration of Pak1.
We propose that Cdc42 interaction disrupts the intramolecular interactions of Pak1, thereby releasing the
kinase from autoinhibition.
The p21-GTPase-activated protein kinase (PAK) family is
present in all eukaryotes. Genetic evidence suggests that STE20,
one of three Saccharomyces cerevisiae homologs of PAK, me-
diates signaling of pheromone response from receptor-coupled
heterotrimeric G proteins to the mitogen-activated protein
kinase (MAPK) cascade, which includes STE11, STE7, and the
pair FUS3 and KSS1 (13, 14, 28). STE20 can phosphorylate
STE11 in vitro (25, 36). Another homolog, CLA4, appears to
regulate normal localization of cell growth and cytokinesis (7),
and a third, SKM1, has broad functions in morphogenesis and
growth (20). In the fission yeast, Schizosaccharomyces pombe,
Pak1 (also known as Shk1) seems to be involved in both sexual
differentiation and morphogenesis (17) and has a structural
and functional homolog, Shk2 (26, 37). Pak1 has been shown
to release the intramolecular and, presumably, autoinhibitory
interactions of Byr2, the S. pombe homolog of STE11 (31).
Mammalian PAK proteins have three major isoforms, and they
appear to be mediators of signaling from members of the
p21-GTPase family such as Rac1 and Cdc42 to the MAPKs
including Jun kinase and p38 MAPKs (1, 3, 6, 11, 23, 27, 38).
All PAKs have an N-terminal regulatory domain and a con-
served C-terminal kinase catalytic domain. The regulatory do-
mains are poorly conserved except for a 70-amino-acid stretch,
named CRIB (Cdc42-Rac interactive binding) domain, which
is known to bind the small Rho-family GTPases (4). Cdc42 can
activate PAK proteins in vitro, inducing a PAK autophosphor-
ylation event (16). Two mechanistic models are consistent with
the in vitro biochemical data: Cdc42-Rac directly induces an
active conformation of the catalytic region, or the GTPases
antagonize an autoinhibitory mechanism.
We have been utilizing genetic analysis and the two-hybrid
system of Fields and Song (8) to probe the regulatory mecha-
nisms of kinases in the RAS signaling pathways of yeast and
mammalian systems (2, 5, 17, 18, 31, 32, 35). Byr2, one of the
S. pombe Ras1 effectors that is required for sexual differenti-
ation, has been analyzed in this way (31). The regulatory do-
main of Byr2 was found to bind to the kinase catalytic domain,
and mutants in the regulatory domain that abolish this inter-
action were activating. Two-hybrid analysis has shown that this
autoinhibitory intramolecular interaction also keeps the kinase
in a closed configuration. With further analysis, we demon-
strated that dominant activated Pak1 induced the open con-
figuration of Byr2. Previous studies had strongly suggested a
role for Pak1 in the integrity of the sexual differentiation path-
ways (17).
Using methods similar to those we have described previ-
ously, we have discovered an intramolecular interaction be-
tween the regulatory and catalytic domains of Pak1. The cat-
alytic domain binds to the same highly conserved region on the
regulatory domain that also binds Cdc42, and we have shown
that wild-type Pak1 exists in a closed configuration with the
kinase catalytic domain masked. We used these observations to
isolate Pak1 mutants that are in an open configuration, with an
accessible catalytic domain. Binding analysis of the regulatory
domains of these Pak1 mutants has shown that they all have
lost the ability to bind the catalytic domain. These results
demonstrate that the intramolecular interaction keeps the ki-
nase in a closed configuration. Moreover, in three different
genetic assays, we have shown that most of these Pak1 mutants
are more active than the wild-type kinase. Therefore, an au-
toinhibitory role for the intramolecular interaction is strongly
suggested. Consistent with the in vitro result that Cdc42 in-
duces PAK autophosphorylation (16), we have found that
Cdc42 can induce the open configuration of Pak1 in vivo.
Based on the conservation among PAK proteins, we propose
that kinase autoinhibition and Cdc42 release of autoinhibition
are general regulatory mechanisms for these protein kinases.
MATERIALS AND METHODS
Yeast, media, and genetic manipulations. S. cerevisiae L40, a lexA-based two-
hybrid reporter strain with both HIS3 and lacZ as reporter genes (33), was used
to study two-hybrid interactions. AN43-5A has a FUS1-lacZ reporter system and
was used to measure the activity of the S. cerevisiae mating signaling pathway
(17). S. cerevisiae cultures were grown in YPD (2% peptone, 1% yeast extract,
2% glucose) or in dropout (DO) synthetic minimal medium (0.67% yeast nitro-
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gen base without amino acids, 2% glucose) with appropriate auxotrophic sup-
plements. The lithium acetate protocol was used for yeast transformation (12).
Generating Pak1 and Cdc42 clones. PCR (24) was used to generate all con-
structs. Pak1-Cat, the kinase catalytic domain of Pak1 that encodes the C-ter-
minal 385 amino acids, was made previously (31). Pak1-Reg, which encodes the
N-terminal 284 amino acids, was made with the following pair of oligonucleo-
tides (boldfacing indicates restriction enzyme sites): AAGGATCCGATGGA
AAGAGGGACTTTACAA, which contains a BamHI site, and GGGGGGTT
GTCGACTAGCATTAGAGGTAGTAGTTTTAAC, which contains a SalI site.
The PCR product was digested with BamHI and SalI and cloned into pGAD and
pLBD vectors. Full-length Pak1 was made by fusing Pak1-Reg to the C-terminal
375 amino acids of Pak1, which was generated by PCR with the following pair of
oligonucleotides: CCCCCCAGTCGACAACCTTCTCCATTAGTTTCCAGC
AAG and AAGGATCCCTGCACGTATTTACCAGAATGATGTATGGA.
The 658-amino-acid full-length Pak1 clone thus had a new SalI site but was
identical to wild-type full-length Pak1 at the amino acid level. Cdc42wt and
Cdc42V12 were made by PCR with the primer pair GGGGATCCGATGCCC
ACCATTAAGTGTGTCGTAGTA, which contains a BamHI site, and CCCTT
GGGTCGACTGCAGTTACAGTACCAAACACTTTGACTTTTT, which con-
tains an overlapping SalI site and a PstI site. The templates for the PCRs were
pREP-Cdc42wt and pREP-Cdc42V12 (kindly provided by Doug Johnson, Uni-
versity of Vermont). Cdc42 sequences were cloned into pGAD and pLBD.
Cdc42 clones with a C189S mutation were made by PCR with the primer pair
GGGGATCCGATGCCCACCATTAAGTGTGTCGTAGTA, which contains a
BamHI site, and CCCCGTCGACAGTACCAAAGACTTTGACTTTTTCTTGT
GAGGAAC, which contains the C189S mutation and a SalI site. Cdc42C189S
sequences were cloned into pGAD, pLBD, and pLS104.
Detection of protein complex formation by the yeast two-hybrid system. To
determine if GAD fusions interact with LBD fusions in the two-hybrid system,
the two fusions were transformed into L40 by the standard lithium acetate yeast
transformation procedure. Cells were plated onto synthetic medium lacking
leucine and tryptophan (DO-LT). Transformants were patched out on fresh
DO-LT plates and examined for histidine prototrophy and b-galactosidase syn-
thesis, since two-hybrid interactions result in transactivation of lexA-HIS3 and
lexA-lacZ. Histidine prototrophy was tested by replicating patches onto medium
lacking leucine, tryptophan, and histidine (DO-LTH) and was evident by growth
on the His2 plates. b-Galactosidase filter assay and liquid assay were conducted
as previously described (32). 5-Bromo-4-chloro-3-indolyl-b-D-galactopyranoside
(X-Gal) was used as the substrate in the b-galactosidase filter assay. o-Nitrophe-
nyl-b-D-galactopyranoside (ONPG) was used as the substrate in the b-galacto-
sidase liquid assay for quantitative measurement.
Making Pak1 regulatory segment fusions by PCR. Four Pak1 regulatory seg-
ments, each about 70 amino acids long, were made by PCR. The DNA fragment
that encodes the first 70 amino acids of Pak1 was made by PCR with the
oligonucleotide pair of AAGGATCCGATGGAAAGAGGGACTTTACAA and
GGGGGTCGACTAGGATTGAGATAAAGGGAAACCGGA; the second 70-
amino-acid fragment was made with the oligonucleotide pair of GTGGATCCA
ATGCGTACAACTGTATCTAGGGTTTCA and GGGGGTCGACTAGCTG
GCAGAGCCTGACCCATAGGA; the third 70-amino-acid fragment was made
with the oligonucleotide pair of GTGGATCCAATGCCTCGCAAATCGACT
GTCATCTCT and GGGGGTCGACTAAAGATATTTCTTGGATTGGGAA
TA; and the last fragment, which is 74 amino acids long, was made with the
oligonucleotide pair of GTGGATCCAATGGAGGAGGGAGCAAAGCCACC
CTTT and GGGGGGTTGTCGACTAGCATTAGAGGTAGTAGTTTTAAC.
The fragments were excised with BamHI and SalI and cloned into pGAD.
To map more precisely the domains mediating Cdc42 and Pak1-Cat interac-
tion, we generated further segment fusions within the stretch of amino acids 141
to 210. Segments starting from amino acids 149, 153, 157, and 161 were made
with the oligonucleotides GTGGATCCAATGTCTCCATTTGATCCGAAGCA
TGTC, GTGGATCCAATGCCGAAGCATGTCACTCACGTTGGT, GTGGA
TCCAATGACTCACGTTGGTTTTAATTATGAT, and GTGGATCCAATGT
TTAATTATGATACTGGGGAATTT, respectively. The segments ending at ami-
no acids 194, 198, 202, and 206 were made with the oligonucleotides GGGGG
TCGACTACTGTGGAGTTTGTACTTGTTCCGA, GGGGGTCGACTAGTC
CAAAACGGCCTGTGGATGTTG, GGGGGTCGACTAAAAAGCCATAGC
GTCCAAAACGGC, and GGGGGTCGACTAGGATTGGGAATAAAAAGC
CATAGC, respectively. The PCR products were excised with BamHI and SalI
and cloned into the pGAD vector.
Creating and screening two-hybrid mutant libraries. We constructed a library
of Pak1 regulatory mutants by PCR mutagenesis of this region (40). We used the
oligonucleotide pair AAGGATCCGATGGAAAGAGGGACTTTACAA and
GGGGGGTTGTCGACTAGCATTAGAGGTAGTAGTTTTAAC, described
above, to amplify and mutagenize wild-type Pak1 template. The PCR product
was gel purified and digested with BamHI and SalI, and full-length Pak1 was
reconstructed by ligation of the PCR products into the LBD fusion vector
containing the C-terminal 375 amino acids of Pak1, as we described above. This
mutant library had a complexity of over 104.
For screening, the pLBD-Pak1 mutant library was transformed into L40 con-
taining pGAD-Pak1-Reg. Cells were plated onto DO-LTH to select for inter-
acting pairs. A total of 3 3 104 clones were screened, and His1 transformants
were patched out on fresh DO-LT for b-galactosidase filter assays. Twenty-five
independent clones were both His1 and LacZ1. pLBD fusion plasmids were
recovered, amplified, and tested individually with GAD-Pak1-Reg and GAD for
binding specificity and reproducibility. Nineteen independent clones were found
to bind Pak1-Reg specifically.
Recovery and amplification of plasmids from yeast cells. To recover plasmids
from yeast cells of interest, the yeast cells were collected and resuspended in 200
ml of lysis buffer (2% Triton X-100, 1% sodium dodecyl sulfate, 0.1 M NaCl, 0.01
M Tris [pH 8], 0.001 M EDTA) and vortexed with equal volumes of glass beads
and phenol-chloroform-isoamyl alcohol (25/24/1 [vol/vol/vol]) at 4°C for 5 min.
After vortexing, cell extracts were centrifuged for 10 min, and the supernatants
were used for electroporation into Escherichia coli. Plasmids were extracted from
E. coli by standard DNA preparation procedures (Qiagen).
RESULTS
A conserved region of the Pak1 regulatory domain interacts
with the catalytic domain. Many protein kinases have a regu-
latory domain that binds to and inhibits the kinase catalytic
domain (29, 31), and we tested if Pak1 has domains capable of
such intramolecular interaction, detectable by two-hybrid in-
teraction. Pak1-Reg, the regulatory domain of Pak1, was fused
to GAD (GAL4 transcription activation domain). The fusion
was tested for interaction with LBD-Pak1-Cat, which is an
LBD (lexA DNA binding domain) fusion of the kinase catalytic
domain of Pak1. LBD-Cdc42V12, which had been shown else-
where to bind GAD-Pak1-Reg (17, 26), was used as a positive
control. GAD and LBD-Ras1 were employed as negative con-
trols. The two-hybrid interaction was determined by histidine
prototrophy and b-galactosidase production (see Materials
and Methods). As shown in Fig. 1, GAD-Pak1-Reg was able to
bind LBD-Cdc42 and LBD-Pak1-Cat, but not LBD-Ras1,
while LBD-Pak1-Cat failed to bind GAD. This result estab-
lished the specific binding between Pak1-Reg and Pak1-Cat. In
keeping with this conclusion, we also tested and found that
GAD-Pak1-Cat can bind LBD-Pak1-Reg faithfully as well
(data not shown). We note in passing that the regulatory do-
main can even bind to a mutant, inactive catalytic domain.
To identify the region on Pak1-Reg that is responsible for
binding Pak1-Cat, we generated several Pak1-Reg deletion
mutants by PCR and tested their ability to bind Pak1-Cat (see
Materials and Methods). We found that a 70-amino-acid
stretch from residues 141 to 210 is able to bind both Cdc42 and
Pak1-Cat specifically (see Fig. 2). This region contains CRIB
(Cdc42-Rac1 interactive binding) domain, the most conserved
region on PAK proteins outside the kinase catalytic domain.
Thus, Pak1-Cat binds to the same region on Pak1-Reg known
to bind Cdc42.
To map more precisely the regions on Pak1-Reg that medi-
ate Cdc42 and Pak1-Cat interactions, several more deletion
mutants within Pak1141–210 were made by PCR (see Materials
and Methods). These deletion mutants were then tested for
binding Cdc42V12, Pak1-Cat, and Ras1, the negative control.
The two-hybrid binding results are also presented in Fig. 2.
We found that truncation from the N-terminal portion of
Pak1141–210 abolished binding to Cdc42 before affecting bind-
ing to Pak1-Cat, whereas truncation from the C terminus abol-
ished binding to Pak1-Cat before binding to Cdc42V12. These
experiments suggest that, in theory, Pak1160–206 should be the
shortest peptide that can bind Pak1-Cat specifically. The ex-
periments described below use slightly larger fragments that do
not bind Cdc42.
Pak1 regulatory domains block truncated and activated
Pak1 in vivo. The standard autoinhibition model for protein
kinases predicts that the regulatory domain inhibits the cata-
lytic activity, and for Pak1, this is supported by the truncation
experiments that have been performed and reported by others
(17, 28). If our two-hybrid data correctly identifies the region
of the regulatory molecule that binds to the catalytic domain,
and the truncated Pak1 is activated because of the loss of the
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inhibitory influence of the regulatory domain, then expression
of that domain should inhibit the activity of the truncated Pak1
when it is expressed in trans. To test this prediction, we ex-
ploited the observation that expression of the truncated Pak1 is
somewhat toxic to S. cerevisiae. We thus performed an expres-
sion toxicity assay. L40 was transformed with either GAD-
Pak1-Reg, GAD-Pak1149–210, GAD-Pak1157–210, or GAD alone,
all carrying the LEU2 marker, and either pLS104-Pak1-Cat or
pLS104 vector alone, each carrying ADE2. Cells were plated
on medium lacking leucine and adenine (DO-LA), and trans-
formants were patched out on fresh DO-LA plates. The
patches were then replica plated and grown for several days on
the nonselective medium, YPD, before being replica plated
back on the selective medium. Cells expressing toxic ADE2
plasmids will tend to lose the same, which we can assay in two
ways: by failure to thrive on the selective plates and by the red
color characteristic of cells lacking ADE2. Cells with Pak1-Cat
and GAD alone failed to grow effectively on the selective me-
dium, and the patches displayed a red color. However, those
with Pak1-Cat with either GAD-Pak1-Reg, GAD-Pak1149–210,
or GAD-Pak1157–210 grew more effectively, and the patches
displayed a pink to white color (Fig. 3). These studies confirm
that the region we have identified not only binds to the cata-
lytic domain but also inhibits it, even when expressed in trans.
Regulatory and catalytic interaction keeps wild-type, full-
length Pak1 in a closed configuration. Since Pak1, like Byr2,
contains a regulatory domain capable of interacting with its
catalytic domain, we suspected that full-length Pak1, like full-
length Byr2, would exist in a closed configuration in which the
catalytic domain is occupied by the regulatory domain. In sup-
port of this hypothesis, we found that although we could read-
ily detect binding between Pak1-Reg and Pak1-Cat, we could
not detect the binding of Pak1-Reg to full-length Pak1, even
though the latter was perfectly capable of binding Cdc42V12,C189S
(Fig. 1). (Note: in these experiments, the Cdc42V12,C189S pro-
tein, lacking the farnesylation site, was used because the com-
bined expression of Pak1 and Cdc42V12 is toxic.) These results
suggest that an intramolecular interaction exists between the
regulatory and catalytic domains in full-length Pak1. This hy-
pothesis is further strengthened by the experiments, described
below, in which we searched for, found, and analyzed mutants
of Pak1 that were in an open configuration.
If we correctly surmise that wild-type Pak1 failed to bind
Pak1-Reg because of intramolecular interactions, we should be
able to readily isolate Pak1 mutants that gain the ability to bind
Pak1-Reg, and such mutants should have regulatory and cat-
alytic domains that are no longer able to interact.
FIG. 1. Binding between the separated regulatory and catalytic domains of Pak1. L40 was transformed with either pGAD, pGAD-Pak1-Reg, or pGAD-
Cdc42V12,C189S and either pLBD-Cdc42V12, pLBD-Pak1-Cat, pLBD-Pak1K415,416R-Cat, pLBD-Ras1, pLBD-Pak1, or pLBD-Pak1-Reg. Transformants were tested for
growth on medium lacking histidine (DO-LTH) and assayed for b-galactosidase production. VSG, very slow growth. Values shown are relative levels (means 6 standard
deviations). DO-LT is the medium lacking leucine and tryptophan. ND, not determined.
FIG. 2. Regions on Pak1-Reg mediating the interaction with the kinase cat-
alytic domain. Pak1-Reg deletion mutants were made by PCR and fused to
GAD. The GAD fusion to the regulatory domain of Byr2 was included as a
control (last row). These fusions were assayed for interactions with LBD fused to
Cdc42, Pak1-Cat, or Ras1 as a negative control. A plus sign represents a two-
hybrid interaction; a minus sign represents no detectable two-hybrid interaction.
The positive interactions were all of about similar intensities. The amino acid
positions of the peptide sequences expressed as GAD fusions are shown. The
conserved region of the Pak1 regulatory domain is shown in gray.
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Pak1-Reg was randomly mutagenized by PCR and fused to
Pak1-Cat in to form a library of LBD fusions of full-length,
mutagenized Pak1. The DNA of this mutant library was trans-
formed into L40 together with GAD-Pak1-Reg, and cells were
plated in the absence of histidine to select for mutant, full-
length Pak1 capable of interacting with the isolated regulatory
domain. Colonies that grew on the His2 plates were patched
out and tested for the production of b-galactosidase. Twenty-
five colonies that were both His1 and LacZ1 were isolated,
and the LBD plasmids from these cells were recovered, am-
plified, and transformed back into L40 together with GAD-
Pak1-Reg or GAD. Nineteen of the 25 LBD-Pak1 plasmids
interacted with GAD-Pak1-Reg but not with GAD. Figure 4
shows the two-hybrid interactions of the 19 LBD-Pak1 mutants
with GAD-Pak1-Reg and with the negative control. Since
these Pak1 mutants can bind Pak1-Reg, we call them Pak1open
mutants hereafter.
The regulatory domains of the 19 Pak1open mutants were
sequenced. All of them contain a single mutation between res-
idues 161 and 200, that is, within the CRIB domain, the highly
conserved region that binds both Cdc42 and Pak1-Cat (Table
1). Several mutations were encountered more than once, and
the mutants fell into 13 groups. All mutations except M200T
and M200R were mapped to residues conserved among PAK
proteins. Figure 5 shows the multiple alignments of this con-
served region with representative homologs, with the sites of
mutation indicated.
As the first step towards characterizing these Pak1open mu-
tants, we tested the binding of the Pak1-Reg of these mutants
to Pak1-Cat and Cdc42. The Pak1-Regs were excised and fused
to GAD, and the GAD fusions were tested with LBD-Pak1-Cat
and LBD-Cdc42, individually. GAD-Pak1wt-Reg and GAD were
tested alongside. The two-hybrid results are presented in Fig.
6. Significantly, but not surprisingly, the regulatory domains of
all of the Pak1open mutants failed to bind LBD-Pak1-Cat, while
all still bound Cdc42 to varying degrees.
These results demonstrate that all 19 Pak1open mutants con-
tain mutations in the CRIB domain that abolish binding to the
catalytic domain Pak1 and argue strongly that the loss of in-
tramolecular interaction is the cause for the open configura-
tion.
Genetic characterizations of Pak1open mutants. If the dis-
ruption of the regulatory-catalytic interactions were sufficient
to activate Pak1, we would expect the Pak1open mutants to be
FIG. 3. Effect of expressing the Pak1 regulatory domain on the toxicity of Pak1-Cat. L40 was transformed with pLS104-Pak1-Cat and either pGAD, pGAD-Pak1-
Reg, pGAD-Pak1149–210, or pGAD-Pak1157–210. Transformants were initially plated and streaked on medium lacking leucine and adenine (DO-LA). The Leu1 and
Ade1 cells were then grown for several days in the nonselective medium, YPD, before being replica plated on the selective medium, DO-LA. Pictures were taken of
the patches, and the color of the patches was noted.
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activated. To test this, we examined the activity of Pak1open
mutants in comparison with that of the wild-type Pak1. Three
phenotypes associated with the dominant activated Pak1,
Pak1-Cat, were assayed: toxicity (references 17 and 26 and as
described above), activation of the FUS1-lacZ reporter system
(17), and the induction of the open configuration of Byr2 (31).
The format for expression toxicity assays was described
above. Pak1, Pak1open mutants, Pak1-Cat, and Pak1K415,416R-
Cat were cloned under an alcohol dehydrogenase promoter
into an ADE2-based 2 mm plasmid, pLS104. L40 cells trans-
formed with various pLS104 clones were plated on Ade2
plates. Transformants were then patched onto fresh Ade2
plates and replica plated on nonselective medium and then
again on Ade2 plates. Cells that grow well while carrying the
pLS104 derivatives grow robustly as white patches on Ade2
plates, while cells with pLS104 derivatives that cause toxicity or
slower growth will not grow as well on Ade2 plates and have a
red to pink color, indicative of defective adenine biosynthesis.
The patches of cells expressing Pak1-Cat, Pak1K415,416R-Cat,
Pak1, or Pak1open mutants are shown in Fig. 7. As expected,
cells containing pLS104-Pak1-Cat failed to grow efficiently on
Ade2 plates after being replica plated, and the patches dis-
played a red color; those containing pLS104 or pLS104-
Pak1K415,416R-Cat grew perfectly well in the absence of ade-
nine, and the patches displayed a white color. Cells containing
pLS104-Pak1 grew well in the absence of adenine, and patches
were light pink, suggesting a very mild toxicity resulting from
the expression of wild-type Pak1. Cells expressing various
Pak1open mutants displayed varying ranges between these two
extremes. Those containing Pak1F161S, Pak1G166W, Pak1E167G,
or Pak1F168S grew well, and their patches exhibited a light
pink color, much like cells with wild-type Pak1; cells with
Pak1W175R, Pak1P193S, Pak1P193Q, Pak1A195V, or Pak1M200R
grew, but their patches were pink; cells with Pak1M200T were
dark pink; and cells with Pak1L179P, Pak1I184T, or Pak1A195T
grew poorly after being replica plated back to the Ade2 plates,
and the patches had a red color, much like those with domi-
nant activated Pak1. From this, we conclude that the majority
of Pak1open mutants have higher activity than wild-type Pak1,
and the results support the model that Pak1 intramolecular
interaction is responsible for autoinhibition.
The FUS1-lacZ reporter system provides an indicator for the
activity of the S. cerevisiae mating signaling pathway (10). We
have shown previously that dominant activated forms of STE20
and Pak1 can activate this pathway in an STE11-dependent
manner (17). It was noted then that full-length wild-type Pak1
failed to activate the pathway. Therefore, we asked if any of the
Pak1open mutants could activate the S. cerevisiae mating path-
way and stimulate b-galactosidase production by the reporter
system. Pak1open mutants were cloned under a galactose-in-
ducible GAL1 promoter, as described in Materials and Meth-
ods, to avoid the potential complications due to the toxicity
of the expressed gene. Cells containing the plasmids were
patched on medium rich in glucose and then replica plated to
medium depleted of glucose but rich in galactose (2%). The
amount of b-galactosidase in these cells was monitored by the
conversion of X-Gal, and the results are presented in Fig. 8. As
expected, cells with Pak1-Cat expressed produced more b-ga-
lactosidase than did cells with the vector alone or cells with
Pak1K415,416R-Cat, the kinase-defective Pak1-Cat. While cells
containing wild-type Pak1 were unable to activate the reporter
system detectably, several of the strains carrying Pak1open mu-
tants were able. In fact, some produced b-galactosidase as well
as did cells carrying Pak1-Cat. These results demonstrate that
some Pak1open mutants are more active than wild-type Pak1
and further confirm that intramolecular interaction is autoin-
hibitory.
The third assay for Pak1 activation was based on its ability to
induce the open configuration of Byr2. We have previously
shown that expression of the dominant activated Pak1, Pak1-
Cat, but not the wild-type full-length kinase, induced the two-
hybrid interaction between GAD-Byr2-CBD (the GAD fusion
to the smallest subregion of the regulatory domain of the Byr2
kinase sufficient to bind to its catalytic domain) and LBD-Byr2
(31). We therefore tested if Pak1open mutants were more ef-
fective than wild-type Pak1 at inducing this interaction. L40
was transformed with pGAD-Byr2-CBD, pLBD-Byr2, and ei-
ther pLS104-Pak1-Cat, pLS104-Pak1K415,416R-Cat, pLS104-
Pak1, pLS104-Pak1I184T, pLS104-Pak1L179P (the two Pak1 mu-
FIG. 4. Binding of the separated regulatory domain to Pak1open mutants.
L40 was transformed individually with either pGAD or pGAD-Pak1-Reg and
either pLBD-Pak1-Cat, pLBD-Pak1, or the 19 pLBD-Pak1open mutants. Trans-
formants were tested for growth on medium lacking histidine (DO-LTH) and
assayed for b-galactosidase production. DO-LT is the medium lacking leucine
and tryptophan.
TABLE 1. Mutations in Pak1open mutants
Mutant group Mutation Member(s)
I F161S Pak1open-1
II G166W Pak1open-9
III E167G Pak1open-17
IV F168S Pak1open-11
V W175R Pak1open-5, Pak1open-10
VI L179P Pak1open-6, Pak1open-18
VII I184T Pak1open-3, Pak1open-12, Pak1open-13,
Pak1open-15
VIII P193S Pak1open-2
IX P193Q Pak1open-19
X A195V Pak1open-4
XI A195T Pak1open-7, Pak1open-8
XII M200T Pak1open-14
XIII M200R Pak1open-16
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tants that were most active in the previous assays), or just
pLS104 vector alone. Transformants were tested quantitatively
for the production of b-galactosidase. The results are pre-
sented in Fig. 9. As expected, Pak1wt-Cat induced the interac-
tion between GAD-Byr2-CBD and LBD-Byr2 to about six
times above the background level, while kinase-defective Pak1-
Cat, Pak1K415,416R-Cat, failed to enhance this interaction.
Wild-type full-length Pak1 also failed to increase this inter-
action, but both Pak1open mutants were able to induce levels
twofold over the background level. These results once again
confirm that the intramolecular interaction is autoinhibi-
tory.
Cdc42 promotes the open configuration of Pak1. It has been
shown in vitro, with a gel overlay assay, that purified Rac-Rho-
Cdc42 can induce an autophosphorylation and activation event
of Pak1 (16). Cdc42 is now known to be an upstream activator
of Pak1 in vivo (17, 26), although the activation mechanism
remains unknown. We have shown that Cdc42 and Pak1-Cat
interact with a tightly overlapping region on Pak1-Reg. More-
over, we failed to find evidence for a trimeric complex among
Cdc42V12, Pak1-Reg, and Pak1-Cat, detectable by the two-
hybrid system, suggesting that the three-way interaction is
sterically forbidden (data not shown). Therefore, we specu-
lated that Cdc42 activates Pak1 by directly relieving Pak1 of
FIG. 5. Location of the altered amino acid residues of the Pak1open mutants in the highly conserved region of PAK proteins. The highly conserved regions on Pak1
(17, 26), STE20 (28), CLA4 (7), and three major mammalian PAK isoforms (3, 16, 21) are aligned, with identical residues in black boxes, conserved residues in grey
boxes, and the residues altered in the Pak1open mutants indicated by arrows.
FIG. 6. Failure of the separated Pak1open regulatory domains to bind the catalytic domain. L40 was transformed individually with either pLBD-Cdc42 or
pLBD-Pak1-Cat and either pGAD, pGAD-Pak1-Reg, or 19 pGAD-Pak1open-Reg. Transformants were tested for growth on medium lacking histidine (DO-LTH) and
assayed for b-galactosidase production. DO-LT is the medium lacking leucine and tryptophan.
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the autoinhibition that results from the intramolecular binding
of the regulatory and catalytic domains. This speculation led us
to predict and test whether Cdc42 could induce the open con-
figuration of Pak1.
We have successfully used the two-hybrid system to identify
signaling components that can induce the open configuration
of Byr2 (31), and we applied the same principles to Pak1. The
Pak1 opening assay was performed in the following fashion:
L40 was transformed with (i) either GAD-Pak1-Reg, GAD-
Pak1149–210, GAD-Pak1157–210, or GAD alone; (ii) either LBD-
Pak1 or LBD-Ras1 as a control; and (iii) either pLS104-
Cdc42V12,C189S, pLS104-Pak1-Cat, pLS104-Pak1K415,416R-Cat,
or pLS104. Cells were patched on medium lacking leucine,
tryptophan, and adenine (for pLS104 plasmid selection) (DO-
LTA). Patches were replica plated on medium lacking histidine
to test the transactivation of the HIS3 reporter gene. Trans-
formants were also tested for lacZ expression, by both filter
overlay and liquid assays. As shown in Fig. 10, only two kinds
of cells displayed an interaction between GAD and LBD
fusions: those expressing GAD-Pak1149–210, LBD-Pak1, and
Cdc42V12,C189S and those expressing GAD-Pak1157–210, LBD-
Pak1, and Cdc42V12,C189S. All other cells failed to display
two-hybrid interactions. These results demonstrate that
Cdc42V12,C189S can effectively and specifically induce the open
configuration of Pak1.
Cells expressing GAD-Pak1-Reg, LBD-Pak1, and Cdc42V12,C189S
did not yield a positive interaction. We attribute this to the fact
that Pak1-Reg, unlike GAD-Pak1149–210 or GAD-Pak1157–210,
also binds Cdc42V12,C189S and thus competes for its binding.
These experiments suggest that Cdc42 opens the configura-
tion of Pak1 through its interaction with the regulatory do-
main. A more direct demonstration of this mechanism was
obtained as follows. We screened for and identified two single-
base-pair mutants of the regulatory domain of Pak1 that failed
to bind Cdc42 yet still were capable of full-strength binding
to the catalytic domain, as judged by two-hybrid interactions.
The mutations, S148A and H155A, were each independent-
ly introduced into the full-length Pak1. We then tested if
Cdc42V12,C189S could induce the open configuration of either
Pak1S14A or Pak1H155A. It could not, indicating that the open-
ing of Pak1 is the consequence of the direct binding of Cdc42
to the regulatory domain.
DISCUSSION
Previous studies showed that the intramolecular interaction
between Byr2 regulatory and kinase catalytic domains keeps
that kinase in a closed configuration and establishes autoinhi-
bition (31). In this report, we first describe a similar potential
for intramolecular interaction within Pak1, the fission yeast
homolog of PAK. Expression of segment fusions indicated that
the highly conserved region of the regulatory domain of Pak1
(Pak1-Reg), to which Cdc42 also binds, was capable of binding
to the catalytic domain. This mapping was later confirmed by
point mutation analysis.
Since this potential Pak1 intramolecular interaction resem-
bles that found in Byr2, we incorporated the insights gained
from Byr2 to guide us in further studies. In particular, we next
demonstrated that Pak1 can exist in the wild-type closed con-
figuration and a mutant open configuration, which differ in
their ability to bind a free regulatory domain. Mutants with the
open configuration have mutations in the conserved regulatory
domain, and these mutant domains are unable to bind sepa-
rated catalytic domains. These studies strongly support the
existence of intramolecular interaction between the regulatory
and catalytic domains of wild-type Pak1.
In the case of Byr2, the intramolecular interaction causes
autoinhibition, and its release is associated with kinase activa-
tion. The same appears to be true for Pak1. First, the expres-
sion of the smallest regulatory region of Pak1 capable of bind-
ing the catalytic region, a region that does not bind to Cdc42,
inhibits the toxicity resulting from expression of the free cata-
lytic domain. Second, the majority of Pak1open mutants are
more active than wild-type Pak1, and some of them behaved
similarly to the activated Pak1 lacking its regulatory domain.
Third, Cdc42, a known activator of Pak1, both in vivo and in
vitro, induces the open configuration, as discussed below.
Our genetic results indicate that not all Pak1open mutants
are equally activated, and none are as active as the construct
which lacks the entire regulatory region. There are many pos-
sible explanations for this. First, these proteins may be ex-
pressed at different levels. Second, although we cannot detect
intramolecular interaction in the mutants by two-hybrid anal-
ysis, the mutants may nevertheless have a closed configuration
in vivo. Third, there may be other features of the regulatory
domain that are inhibitory for full biological activity. Indeed,
other proteins that bind to the regulatory domain of Pak1 have
recently been identified (9). Our studies are not designed to
resolve these questions.
FIG. 7. Expression toxicity assay with Pak1open mutants. L40 was trans-
formed with either pLS104, pLS104-Pak1-Cat, pLS104-Pak1K415,416R-Cat, pLS104-
Pak1, or 13 pLS104-Pak1open mutants. Transformants were initially plated and
then patched in groups of four on medium lacking adenine. The Ade1 cells were
then replica plated on the nonselective medium, YPD, for several days, before
being replica plated on medium lacking adenine (DO-adenine). Pictures were
taken of the patches on DO-adenine, and the color of the patches was noted. The
wild-type ADE2 allele was included for comparison.
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In our previous studies, we found that activated Pak1 could
induce the open configuration of Byr2. We suspected that
Cdc42 might do the same to Pak1. First, it was known that
Cdc42 was an activator. Second, Cdc42 and the catalytic
domain bind to overlapping regions of the regulatory do-
main. Third, we could not observe a stable trimeric complex
among Cdc42, Pak1-Reg, and Pak1-Cat. We thus tested if
Cdc42 could open Pak1. We used three different molecular
probes for the open configuration of Pak1: GAD-Pak1-Reg,
GAD-Pak1149–210, and GAD-Pak1157–210. None are able to
bind full-length Pak1, all three are able to bind the isolated
catalytic domain, and only the first is also able to bind Cdc42.
Indeed, when Cdc42 was overexpressed, the release of the
kinase catalytic domain of full-length Pak1 to bind GAD-
Pak1149–210 and GAD-Pak1157–210 was clear. Moreover, open-
ing by Cdc42 could not be observed on mutant Pak1 proteins
that do not bind Cdc42.
Although Cdc42 does activate Pak1, binds to Pak1, and
opens its conformation and the open-conformation mutants
are more active than wild type, these experiments do not rule
out additional functions for Cdc42 in the activation of Pak1.
For example, Cdc42 may facilitate the localization of Pak1 or
the binding of other activating proteins.
It may be useful to draw a parallel between the interactions
of Cdc42 and those of Ras1 with their respective protein kinase
targets. Many of the same relations are retained: Ras1 is an in
vivo regulator of Byr2, it binds directly to Byr2, and its domain
of interaction overlaps with the site where the catalytic subunit
also binds (22, 31, 32). Yet we were unable to demonstrate the
opening of Byr2 by Ras1. In fact, no direct in vitro activation of
Byr2 by Ras1 (or of Raf by H-ras) has been observed, and we
have observed a stable complex between Ras1 and the Byr2
catalytic domain bridged by a mutant regulatory domain of
Byr2 with enhanced affinity for the catalytic domain (30a).
Thus, the mechanisms of action of these two very similar
GTPases on two similar protein kinases are likely to be very
different.
FIG. 8. Activity of the Pak1open mutants in the FUS1-lacZ induction assay. AN43-5A was transformed with either pYX113 (the empty vector with the GAL1
promoter), pYX113-Pak1-Cat, pYX113-Pak1K415,416R-Cat, pYX113-Pak1, 13 of the pYX113-Pak1open mutants, or pYX113-lacZ. Transformants were subjected to a
20-h galactose induction before being assayed for b-galactosidase production from the FUS1 promoter. Overlay filters were incubated with X-Gal for 2 to 6 h, and results
of quadruplicate transformants are shown. Cultures were also harvested for b-galactosidase liquid assays, performed on four independent transformants. The assay
results, 6 standard deviations, are shown at right.
FIG. 9. Induction of the open configuration of Byr2 by the overexpression of
Pak1open mutants. L40 was transformed with either pGAD-Byr2-CBD or pGAD;
either pLBD-Byr2 or pLBD-Lamin; and either pLS104-Pak1-Cat, pLS104-
Pak1K415,416R-Cat, pLS104-Pak1wt, pLS104-Pak1I184T, pLS104-Pak1L179P, or just
the pLS104 vector alone. Transformants were tested quantitatively for b-galac-
tosidase production. Values shown are relative levels. Standard deviations from
at least four independent transformants are shown by error bars.
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The region of the Pak1 regulatory domain that can bind to
both Cdc42 and the catalytic domain is highly conserved
among all members of the PAK family. Hence, this intramo-
lecular interaction is highly likely to be conserved among them
as well. Indeed, during the preparation of this paper, Zhao et
al. reported the identification of a conserved negative regula-
tory region in aPAK (39). The authors showed that mutations
on residues 101 to 137 of aPAK render that kinase constitu-
tively active. They further provided evidence that aPAK83–149,
a 67-amino-acid peptide, can block PAK activation by Cdc42 in
vitro and suppresses PAK functions in vivo. This conserved
negative regulatory region on aPAK corresponds to the Pak1
autoinhibitory region reported here. Our results are exactly
complementary.
It may be proper to think of four kinases comprising the
prototypic MAPK module: MAPK, MEK, MEKK, and PAK.
MAPKs and MEKs have limited regions outside of the kinase
catalytic domain and need to be phosphorylated at conserved
residues in the catalytic domain to gain maximum kinase
activities (34) (reviewed in reference 19). Thus, MEKs and
MAPKs are predominantly regulated by dynamic phosphory-
lation and dephosphorylation and perhaps do not display au-
toregulation. MEKKs, such as Mekks, STE11, Byr2, and Raf,
have long regulatory domains, which may bind and mask the
kinase catalytic domains, and thus are kept in inactive form.
MEKK autoregulation can be antagonized by PAK phosphor-
ylation. PAKs, like MEKKs, also utilize regulatory and cata-
lytic interaction to exert kinase autoregulation. Both PAKs and
MEKKs can be regulated by p21 GTPases. However, while
PAK regulation by Rho-family GTPases may be caused in
part by direct release from autoinhibition, the regulation of
MEKKs by GTPases may be more indirect (15, 30).
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